Spots Global Cancer Trial Database for gardasil

Every month we try and update this database with for gardasil cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine	NCT00501137	Cervical Cancer Genital Warts	HPV (Human Papi...	9 Years - 26 Years	University of British Columbia
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)	NCT02653118	Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma...	V503 GARDASIL	16 Years - 26 Years	Merck Sharp & Dohme LLC
HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL	NCT03947775	Anal Intraepith... Anal Cancer Human Papilloma...	9-valent HPV va...	18 Years -	University Health Network, Toronto
Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making	NCT00807898	Cervical Cancer		13 Years -	University of Louisville
Immunogenicity and Safety Study of NBP615 in Healthy Female	NCT04453241	Cervical Cancer	NBP615 Gardasil	9 Years - 26 Years	SK Bioscience Co., Ltd.
Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil	NCT00524745	Dose Schedule S...	Biological: qua...	11 Years - 13 Years	PATH
Acceptance of Human Papillomavirus Vaccination in Postpartum Women	NCT00730704	Human Papilloma... HPV Post Partum		18 Years - 26 Years	Columbia University
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults	NCT00798265	Human Immunodef... Human Papilloma... Adolescent Papillomavirus ...	Gardasil Survey	12 Years - 26 Years	National Institutes of Health Clinical Center (CC)
A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)	NCT02114385	Papilloma Viral...	V503 GARDASIL	16 Years - 26 Years	Merck Sharp & Dohme LLC
Acceptance of Human Papillomavirus Vaccination in Postpartum Women	NCT00730704	Human Papilloma... HPV Post Partum		18 Years - 26 Years	Columbia University
Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL	NCT01928225	Cervical High G...	Human Papilloma...	18 Years -	University of Witwatersrand, South Africa
Human Papillomavirus Screening and Vaccine Readiness Program	NCT00863096	Human Papilloma...	Gardasil	18 Years - 45 Years	Public Health Research Institute, India
Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making	NCT00807898	Cervical Cancer		13 Years -	University of Louisville
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study	NCT01133509	Genital Human P...	Gardasil	18 Years - 26 Years	Eastern Virginia Medical School
Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities	NCT00501189	Papillomavirus ...	human papilloma...	18 Years - 26 Years	Eisenhower Army Medical Center
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females	NCT01031069	Infections, Pap... Papillomavirus ...	GSK Biologicals... Merck's Human P...	15 Years - 25 Years	GlaxoSmithKline
Human Papillomavirus Screening and Vaccine Readiness Program	NCT00863096	Human Papilloma...	Gardasil	18 Years - 45 Years	Public Health Research Institute, India
Impact of HPV Vaccine On The Prevalence Of HPV In Norway	NCT02934724	Cervical Intrae... Cervical Cancer Oropharyngeal C...	Self sample fro... Self sample fro... Questionnaire	18 Years - 20 Years	Oslo University Hospital
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen	NCT04206813	HPV Infection	Gardasil 9 2 do... Gardasil 9 3 do... Gardasil 9 resc...	16 Years - 45 Years	Boston Medical Center
HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)	NCT02087384	AIN HIV	Gardasil Placebo	18 Years -	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Impact of HPV Vaccine On The Prevalence Of HPV In Norway	NCT02934724	Cervical Intrae... Cervical Cancer Oropharyngeal C...	Self sample fro... Self sample fro... Questionnaire	18 Years - 20 Years	Oslo University Hospital
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen	NCT04206813	HPV Infection	Gardasil 9 2 do... Gardasil 9 3 do... Gardasil 9 resc...	16 Years - 45 Years	Boston Medical Center
The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru	NCT01338051	Cervical Intrae... Cervical Cancer Cervical Neopla... Cervical Dyspla... Human Papilloma...	Gardasil	30 Years - 45 Years	Preventive Oncology International, Inc.
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection	NCT00513526	Infection Precancerous Co...	Gardasil	18 Years -	AIDS Malignancy Consortium
Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls	NCT00956553	HPV Infections	Cervarix Gardasil	13 Years - 15 Years	Public Health England
Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL	NCT01928225	Cervical High G...	Human Papilloma...	18 Years -	University of Witwatersrand, South Africa
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection	NCT00513526	Infection Precancerous Co...	Gardasil	18 Years -	AIDS Malignancy Consortium
Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men	NCT00666107	Anal Cancer HIV Infections	Gardasil	18 Years -	Southern California Institute for Research and Education
Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers	NCT00925288	Human Papilloma...	Gardasil	18 Years - 26 Years	Johns Hopkins Bloomberg School of Public Health
Acceptance of Human Papillomavirus Vaccination in Postpartum Women	NCT00730704	Human Papilloma... HPV Post Partum		18 Years - 26 Years	Columbia University
Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities	NCT00501189	Papillomavirus ...	human papilloma...	18 Years - 26 Years	Eisenhower Army Medical Center
Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL	NCT01928225	Cervical High G...	Human Papilloma...	18 Years -	University of Witwatersrand, South Africa
Acceptance of Human Papillomavirus Vaccination in Postpartum Women	NCT00730704	Human Papilloma... HPV Post Partum		18 Years - 26 Years	Columbia University
FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program	NCT03105856	Cervical Intrae... HPV-Related Cer...	CERVARIX GARDASIL	25 Years - 45 Years	Instituto Nacional de Salud Publica, Mexico
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine	NCT00501137	Cervical Cancer Genital Warts	HPV (Human Papi...	9 Years - 26 Years	University of British Columbia
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)	NCT03998254	Papillomavirus ...	V503 Gardasil	20 Years - 45 Years	Merck Sharp & Dohme LLC
The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years	NCT04022148	Cancer of Cervi... Vaccinia	Gardasil	27 Years - 45 Years	University of Fukui

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world:

Spots Global Cancer Trial Database for gardasil

Every month we try and update this database with for gardasil cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for gardasil cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.